These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 30183664

  • 21. Critical issues of PTH assays in CKD.
    Komaba H, Goto S, Fukagawa M.
    Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Parathyroid hormone assay: problems and opportunities.
    Martin KJ, González EA.
    Pediatr Nephrol; 2007 Oct; 22(10):1651-4. PubMed ID: 17574479
    [Abstract] [Full Text] [Related]

  • 26. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.
    Saab G, Whaley-Connell A, McFarlane SI, Li S, Chen SC, Sowers JR, McCullough PA, Bakris GL, Kidney Early Evaluation Program Investigators.
    Metabolism; 2010 Mar; 59(3):385-9. PubMed ID: 19800639
    [Abstract] [Full Text] [Related]

  • 27. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Mar; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR.
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [Abstract] [Full Text] [Related]

  • 30. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.
    Cozzolino M, Brancaccio D, Cannella G, Messa P, Gesualdo L, Marangella M, LoDeserto C, Pozzato M, Rombolà G, Costanzo AM, di Luzio Paparatti U, Mazzaferro S, FARO Study Group.
    Nephrol Dial Transplant; 2012 Sep; 27(9):3588-94. PubMed ID: 22523119
    [Abstract] [Full Text] [Related]

  • 31. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, Tsubakihara Y, Rakugi H, Takahara S, Isaka Y.
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays.
    Schleck ML, Souberbielle JC, Delanaye P, Plebani M, Cavalier E.
    Clin Chem Lab Med; 2017 Jul 26; 55(8):1152-1159. PubMed ID: 28099122
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.
    Nephrol Dial Transplant; 2003 Apr 26; 18(4):759-68. PubMed ID: 12637646
    [Abstract] [Full Text] [Related]

  • 37. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 26; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 38. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
    Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ.
    Am J Kidney Dis; 2007 Jul 26; 50(1):59-68. PubMed ID: 17591525
    [Abstract] [Full Text] [Related]

  • 39. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG.
    Blood Purif; 2003 Jul 26; 21(1):118-23. PubMed ID: 12596757
    [Abstract] [Full Text] [Related]

  • 40. Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Yamamoto S, Karaboyas A, Komaba H, Taniguchi M, Nomura T, Bieber BA, De Sequera P, Christensson A, Pisoni RL, Robinson BM, Fukagawa M.
    BMC Nephrol; 2018 Oct 05; 19(1):253. PubMed ID: 30290781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.